Richard Saynor runs Sandoz. Sandoz makes generic drugs. The drugs cost nothing to make and somehow still cost too much to buy. Now Trump wants tariffs on imported generics and Saynor warns prices will climb or supply will vanish. This assumes supply exists now. It assumes prices aren't already insane. Bold claims from a man selling pills.
The threat works like this: tariffs hit imports, manufacturers eat the cost or pass it along, patients pay more for the same molecule they've been overpaying for since 2003. Saynor frames this as a crisis. He's technically correct. The crisis started decades ago when pharma companies realized they could charge Americans seventeen times what they charge Norwegians for identical tablets and nobody would guillotine them for it.
Retail traders heard "tariff threat" and immediately began building positions in pharma ETFs because they read somewhere that volatility equals opportunity. They did not read the part about generics having margins thinner than gas station sushi. They did not read anything. They saw a headline with the word "Trump" and started clicking buttons like a pigeon in a Skinner box who's been promised cocaine but keeps getting electrocuted.
Saynor could've said nothing. He could've waited for the tariffs to maybe happen and then quietly raised prices like every other pharma CEO does every January without explanation or apology. Instead he went public with a warning so vague it applies to literally every imported product in America. Brave stuff. Real profile in courage.
The funniest part isn't that patients will pay more. They already pay more. The funniest part is that Saynor thinks announcing it in advance will somehow prevent it, as if Trump reads Swiss pharma press releases before signing executive orders, as if anyone with tariff authority has ever reconsidered based on the input of a guy whose company name sounds like a prescription antifungal.
Photo by Peter Steiner 🇨🇭 1973 on Unsplash
Leave a Comment